Thymus, Antibodies, and Muscle Weakness in Myasthenia Gravis
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study examines how the thymus gland and specific antibodies relate to myasthenia gravis, a condition causing muscle weakness. Researchers will compare people with different thymus problems and antibody patterns to better understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Able to provide written consent and follow study procedures
- Have a blood sample available to test for myasthenia gravis-related antibodies
- Have recent chest imaging (CT or MRI scan) available for review
- Fall into one of four study groups based on thymus health and antibody status
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer drug combination (EFG) works better than standard immunoglobulin (IVIG) for people who have both thymoma and myasthenia gravis and need surgery to remove the thymoma. The goal is to improve symptoms before and after the operation.
This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.
This study looks at what helps predict outcomes in people with myasthenia gravis (MG). It may help doctors better forecast how MG will progress and which factors matter most for recovery and long-term health.
This study looks at sexual and urinary problems in people with generalized myasthenia gravis. It uses questionnaires to understand these issues and how they affect quality of life.
This study uses lab-grown mini muscle-nerve cells (organoids) to better understand severe, hard-to-treat myasthenia gravis. It may help researchers find new treatment options for people with the AChR antibody type.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
Hear when a new Myasthenia Gravis Associated With Thymoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.